WILSON JAMES N sold CORT

June 16, 2026 · Form 4 insider transaction

WILSON JAMES N sold 5,823 shares of Corcept Therapeutics Incorporated at $83.57 per share, a transaction worth $486.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
5,823
Price
$83.57
Total value
$486.6K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after1,094,543
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.; Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.16 to $83.935 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.; Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR